Condition: Chemotherapy-induced Peripheral Neuropathy · Sponsor: University of Southern Denmark
Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.
This description comes directly from the study's public registry record.
Ditte Bork Iversen, MSc Pharm, PhD · +45 65 50 23 52 · dbiversen@health.sdu.dk
Tore B. Stage, Prof · +45 65 50 36 78 · tstage@health.sdu.dk
Always discuss trial participation with your own doctor first.
| Odense University Hospital | Odense, Denmark | Recruiting |
| University Hospital of Southern Denmark, Sønderborg | Sønderborg, Denmark | Recruiting |
| University Hospital of Southern Denmark, Vejle | Vejle, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06430814